Sort
85,873 grants matching “alzheimers”
Impact of ovarian hormone suppression on regional and global brain architecture and cognition
$957,685Matthew S Panizzon · University Of California, San Diego · R01 · FY2021 · AG
Novel Dopaminergic Stimulant Prodrug for the Treatment of Apathy in AD
$957,571Sandeep Patil · Praxis Bioresearch, Llc · R44 · FY2022 · AG
Decode Mitochondrial Morphology Dynamics to Predict Cell Fate Decisions
$957,500Johannes Schoeneberg · University Of California, San Diego · DP2 · FY2025 · GM
Systems Genetics Analysis of Resilience to Alzheimerâs disease
$957,453Catherine Cook Kaczorowski · Jackson Laboratory · R01 · FY2021 · AG
Advancing Geriatrics Infrastructure and Network Growth (AGING) Initiative
$957,316Jerry H Gurwitz · Univ Of Massachusetts Med Sch Worcester · R33 · FY2023 · AG
Longitudinal Cognitive ERP studies: Advancement for AD Clinical Trials
$957,278John M Olichney · University Of California At Davis · R01 · FY2016 · AG
Metabolic Networks and Pathways in Alzheimer's Disease
$957,041Rima F Kaddurah-Daouk · Duke University · R01 · FY2015 · AG
Clinical Core B
$956,997Douglas R Galasko · University Of California, San Diego · P50 · FY2010 · AG
Spreading Tau Pathology in Non-Amnestic Alzheimer's Disease
$956,703Jeffrey S Phillips · University Of Pennsylvania · R01 · FY2023 · AG
UAMS Alzheimer's Disease Core Center
$955,804University Of Arkansas Med Scis Ltl Rock · P30 · FY2002 · AG
FitMi AD: a safe and motivating computer-guided exercise system for individuals with MCI or mild dementia due to Alzheimer's disease
$955,742Daniel Zondervan · Flint Rehabilitation Devices · R44 · FY2022 · AG
The Effects of COVID-19 on the Well-being, Cognition and Mortality of Persons Living With Dementia
$955,699Michael D Hurd · Rand Corporation · R01 · FY2024 · AG
Neural mechanisms of gait disturbances as individualized digital biomarker trajectories in preclinical dementia
$955,432Ehsan Adeli · Stanford University · R01 · FY2024 · AG
Phase II RCT of High-dose Vitamin D Supplements in Older Adults without Dementia
$955,397John M Olichney · University Of California At Davis · R01 · FY2021 · AG
Core B: University of Kentucky Alzheimer's Disease Core Center
$955,337Gregory A Jicha · University Of Kentucky · P30 · FY2025 · AG
Multi-site longitudinal Integrated Neurocognitive and Sleep-Behavior Profiler for the Endophenotypic Classification of Dementia Subtypes (INSPECDS)
$955,309Chris Berka · Advanced Brain Monitoring, Inc. · R44 · FY2024 · AG
Biospecimen Core
$955,307Bharat Thyagarajan · Washington University · U19 · FY2023 · AG
24-hour Activity Cycles to Optimize Cognitive Resilience to Alzheimer's Disease in African Americans: The Jackson Heart Study
$955,061Kelley Pettee Gabriel · University Of Alabama At Birmingham · R01 · FY2021 · AG
Monitoring real-world driver behavior for classification and early prediction of Alzheimerâs disease
$954,904Matthew Rizzo · University Of Nebraska Medical Center · R01 · FY2020 · AG
GMP Production of a Tau Oligomer Inhibitor to Enable Clinical Development for ADRD
$954,537James G. Moe · Oligomerix, Inc · R44 · FY2020 · AG
Project III "Cognitive Difficulty in LB and AD Dementias"
$954,391Murray Grossman · University Of Pennsylvania · U19 · FY2022 · AG
Consumer Health Information Technology to Engage and Support ADRD Caregivers: Research Program to Address ADRD Implementation MIlestone 13.I
$954,276Jennifer L Wolff · Johns Hopkins University · R35 · FY2021 · AG
NEUROSCIENCE CORE CENTER
$954,269Francis W Flynn · University Of Wyoming · P30 · FY2013 · GM
Modified Ketogenic Diet Effects on Alzheimer's Disease Biomarkers and Cognition in Mild Cognitive Impairment
$954,203Suzanne Craft · Wake Forest University Health Sciences · R01 · FY2017 · AG
Targeting Multiple Diseases Through Gamma Secretase
$954,099Barbara A Osborne · University Of Massachusetts Amherst · P01 · FY2010 · AG